What question did this study set out to answer?

The research aims to explore how CEBPA mutations impact prognosis in acute myeloid leukaemia patients.

CCAAT/enhancer‐binding protein alpha basic leucine zipper in‐frame insertion/deletion ( CEBPA bZIP ‐ InDel ‐inf) defines a favourable‐prognosis subgroup in CEBPA ‐mutated acute myeloid leukaemia

View Full Paper

Ask AI

Bookmark

Authors

Investigates the poor prognosis factors in CEBPA-mutated AML, suggesting CEBPA bZIP-InDel-inf as a favorable subgroup.

The research aims to explore how CEBPA mutations impact prognosis in acute myeloid leukaemia patients.
Analysis of clinical and genetic features in 93 AML patients with CEBPA mutations, focusing on 56 with bZIP-InDel-inf.
Development of survival censoring models using inverse probability weighting and Cox regression analyses.
Risk stratification for overall survival and relapse-free survival based on genetic variables.
Patients with CEBPA bZIP-InDel-inf had better overall survival and relapse-free survival compared to CEBPA non-InDel.
Higher white blood cell count, blast cell count, and M4/M5 phenotype were linked to worse overall survival.
Lower hemoglobin levels and higher variant allele frequency independently predicted worse relapse-free survival.

Yang et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark